Cardiology
Clinical
Triple therapy in question
Clinical question: In patients with nonvalvular atrial fibrillation undergoing percutaneous coronary intervention (PCI), is dabigatran plus a...
Clinical
Rivaroxaban lowers cardiovascular risk but increases bleeding risk
Is rivaroxaban alone or in combination with aspirin more effective than is aspirin alone in preventing cardiovascular events in patients with...
Clinical
Check orthostatic vital signs within 1 minute
What is the relationship between timing of measurement of postural blood pressure (BP) and adverse clinical outcomes?
Clinical
How to manage a patient presenting with syncope
Obtaining a detailed history is crucial to determining which patients with syncope are at high risk for adverse outcomes.
News
Thrombectomy shines in presence of a clinical deficit and imaging mismatch
Less disability, greater functional independence, and less neurologic deterioration was observed for thrombectomy plus standard care.
Clinical
Short Takes
A brief roundup of HM-centric research.
News
ACC guidance addresses newer HFrEF options
Opportunities are being missed.
News
FDA approves angiotensin II for shock patients
Treatment option for critically ill hypotensive patients who do not adequately respond to available therapies.
Clinical
Journal of Hospital Medicine – Dec. 2017
Read the latest research from the Journal of Hospital Medicine, the premier publication for dissemination of research and education for the...
Clinical
Use of the dual-antiplatelet therapy score to guide treatment duration after percutaneous coronary intervention
Clinical question: Can the dual-antiplatelet therapy scoring system be used to determine which patients undergoing percutaneous...